Nutra Pharma NPHC
Nutra Pharma: quarterly report (amended) for the quarter ended Sep 30, 2010
- Form
- 10-Q/A
- Filed
- Period
- Importance
- Routine
- Accession
- 0001144204-11-000684
- Document
- 10-Q/A
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2833 and related industry codes: the same peer list as the financial tables.
- International Stem Cell ISCO public float $592K, Jun 30, 2025
- Emmaus Life Sciences EMMA public float $582K, Jun 30, 2025
- Mosaic ImmunoEngineering CPMV public float $856K, Jun 30, 2025
- Avenue Therapeutics ATXI public float $572K, Jun 30, 2025
- China Foods Holdings CFOO public float $864K, Jun 30, 2025
